The most used antigenic targets are CD19, erb-b2 receptortyrosine kinase 2 (ERBB2), HER2, CD22, CD30, CD33, CD79b, and Mesothelin(MSLN).46 These antigenic markers varydepending on the tumor type. This evidence concerns the gene MSLN and neoplasm.